Author(s):
Ranjini D.M, Sadiq Basha G, Prabakaran N.
Email(s):
ranjinidm56@gmail.com , gsadiqbasha@gmail.com
DOI:
10.52711/0974-360X.2021.00600
Address:
Ranjini D.M*, Sadiq Basha G, Prabakaran N.
1Regulatory Executive in Generic Formulation Regulatory Science, Biocon Pharma Limited, 20th KM, Hosur Road, Electronic City, Bengaluru, Karnataka 5600100.
2Associate Vice President – Regulatory Science Biocon Pharma Limited, 20th KM, Hosur Road, Electronic City, Bengaluru, Karnataka 5600100.
3Manager in Regulatory Sciences – Generic Formulations Biocon Pharma Limited, 20th KM, Hosur Road, Electronic City, Bengaluru, Karnataka 5600100.
*Corresponding Author
Published In:
Volume - 14,
Issue - 6,
Year - 2021
Cite this article:
Ranjini D.M, Sadiq Basha G, Prabakaran N. Regulatory Strategies for Orphan drug Development in USA–Europe. Research Journal of Pharmacy and Technology. 2021; 14(6):3449-4. doi: 10.52711/0974-360X.2021.00600